Clinical Trials Logo

Filter by:
NCT ID: NCT00768456 Completed - Pain, Postoperative Clinical Trials

Local Infiltration Analgesia With Ropivacaine Versus Placebo in Vaginal Hysterectomy: a Randomized, Double-Blind Study

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare systematic local infiltration with Ropivacaine 0.5 % vs. Placebo in patients undergoing vaginal hysterectomy. The hypothesis is that systematic local infiltration will reduce postoperative pain and postoperative opioid consumption.

NCT ID: NCT00767325 Completed - Clinical trials for Rheumatoid Arthritis

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography

Start date: December 2008
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess early signs of response to abatacept+methotrexate in metacarpophalangeal joints in both hands using power Doppler ultrasonography in patients with active rheumatoid arthritis.

NCT ID: NCT00766909 Completed - Clinical trials for Diabetes Mellitus Nos New Onset

Diabetogenicity of Cyclosporine and Tacrolimus

CSATAC
Start date: March 2008
Phase: Phase 4
Study type: Interventional

Cyclosporine (CsA) and Tacrolimus (Tac) are immunosuppressive agents comprising the cornerstone of treatment among organ transplant recipients. Unfortunately diabetes is a known complication after transplantation, yet the underlying mechanisms of this type of diabetes are still unresolved. A direct comparison of the diabetogenic effects of CsA and Tac, without interference of corticosteroid treatment, has not yet been investigated using a hyperinsulinemic euglycemic glucose clamp technique, which is the best method for estimating insulin sensitivity. Randomized, investigator-blinded cross-over studies will be carried out, studying 10 healthy subjects and 10 hemodialysis patients. Each participant will receive treatment with CsA, Tac and placebo respectively in a random order. The results will be of relevance to the choice and monitoring of immunosuppressive regimens in kidney transplant recipients as well as the development of better treatment modalities for diabetes.

NCT ID: NCT00765674 Completed - Hypertension Clinical Trials

Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension

Start date: September 2008
Phase: Phase 3
Study type: Interventional

This study evaluated the efficacy (blood pressure lowering effect) and safety of aliskiren/amlodipine/hydrochlorothiazide in patients with moderate to severe hypertension.

NCT ID: NCT00765453 Completed - Clinical trials for Acute Myocardial Infarction

Bone Marrow Derived Adult Stem Cells for Acute Anterior Myocardial Infarction

REGEN-AMI
Start date: March 2008
Phase: N/A
Study type: Interventional

Study hypothesis : The purpose of this study is to determine whether Intracoronary infusion of autologous bone marrow derived progenitor cells to patients undergoing primary angioplasty for acute anterior myocardial infarction will lead to an improvement in cardiac function greater than that seen by placebo alone. Aims - To demonstrate that it is safe and feasible to deliver autologous bone marrow derived stem cells within hours of the primary angioplasty procedure - To demonstrate the effects of autologous bone marrow derived stem cells on cardiac function using cardiac MRI (or cardiac CT), echocardiography and left ventriculography. - To demonstrate the effect of autologous bone marrow derived stem cells in addition to standard care leads to improvement in cardiac function compared to patients saline(placebo) and standard care.

NCT ID: NCT00765063 Completed - Diabetic Foot Ulcer Clinical Trials

The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

Start date: October 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective of this 6 month open-label extension trial is to evaluate long-term safety and tolerability of dalteparin in treatment of chronic neuroischaemic foot ulcers in diabetic patients with peripheral arterial occlusive disease (PAOD) and peripheral neuropathy.

NCT ID: NCT00761449 Completed - AML Clinical Trials

Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5

Start date: October 2007
Phase: Phase 2
Study type: Interventional

The aim of this study is to investigate the efficacy of lenalidomide in high risk MDS or AML with chromosome 5 aberrations.

NCT ID: NCT00761007 Completed - Clinical trials for Irritable Bowel Syndrome

Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)

IRIS
Start date: July 2008
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the benefit of treatment with oral dose of Ibodutant (code: MEN 15596) on IBS symptoms and the safety and tolerability of this therapy.

NCT ID: NCT00760695 Completed - Anorexia Nervosa Clinical Trials

Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa

Start date: October 2008
Phase: Phase 3
Study type: Interventional

A pilot study designed to reveal the effects of Marinol / dronabinol, a CB 1 agonist. Primary end point: To estimate weight gain and EDI scores in patients receiving Marinol compared to placebo Secondary end points: Motor and inner restlessness and hormonal changes during the treatment.

NCT ID: NCT00760370 Completed - Breast Cancer Clinical Trials

Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer

Start date: December 2008
Phase: Phase 2
Study type: Interventional

The investigators major aim is to determine whether there is a difference in the retention of zoledronic acid in multiple myeloma patients, compared to patients with breast cancer metastasis to bone. In addition the investigators wish to analyze if the retention of zoledronic acid is correlated to the extent of bone resorption/formation, and if there is a tendency to changes in retention with sequential treatment.